Upcoming Events

Strategies for Improving Public Understanding of FDA-Regulated Products Virtual Public Meeting
Mitigating Risks from Human Xylazine Exposure Public Meeting: In-person and Virtual 

Past Events

- On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features.
RAISE: Lessons Learned & Practical Applications for the Future June 15, 2023 2-4 pm ET  
RAISE: Reactions to Barriers, Facilitators, and Proposed Solutions Thursday, June 1, 2023 2-3 PM ET
RAISE: Advanced Analytics: Interim Solutions When Race & Ethnicity are Missing
- Considerations for Buprenorphine Initiation and Maintenance Care Wednesday, May 10, 2023, 1 – 4:45 pm ET
RAISE: Considerations in the Measurement of Race and Ethnicity, Downstream Effects, and Novel Methods to Address the Issues
RAISE: Missingness, Misclassification, and Measurement Bias in Race and Ethnicity Thursday, April 20, 2023 2-3 PM ET
RAISE: Technical Challenges in the Transfer of Information  Thursday, April 6, 2023 2-3 PM ET